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Transcription is obviously essential, but even a good thing can be dangerous at times. In this issue, 
Lin et al. (2009) provide evidence that binding of the transcription machinery may predispose 
genome regions to breakage and translocations that may lead to cancer.Nearly all cancer cells contain abnormal 
chromosomes. Of particular importance 
are chromosomal translocations that 
form when chromosomes suffer breaks 
but are not properly repaired and then 
illegitimately fuse to each other. Although 
translocations are sometimes secondary 
events in tumors, translocated chromo-
somes can be causal in some cancers. 
Despite their prevalence and impor-
tance, little is known about how cancer 
translocations form in an intact cell. In 
this issue of Cell, Lin et al. (2009) out-
line several molecular events leading to 
chromosome translocations. What they 
find suggests a prominent role for chro-
matin structure in predisposing genome 
regions for breakage, and their results 
may provide an explanation for the well-
known cell-type specificity of some 
chromosomal translocations.
Lin et al. use prostate cancer as a 
model to study translocation mecha-
nisms (Lin et al., 2009). This is a useful 
system, as an estimated 50%–70% of 
prostate tumors contain translocations 
between the TMPRSS2 gene on chro-
mosome 21 and the ERG or ETV1 loci 
on chromosomes 21 and 7, respectively 
(Tomlins et al., 2005). TMPRSS2 is a tar-
get gene of male androgen hormones, 
which play a critical role in prostate 
development and tumor formation. Lin 
et al. first asked whether androgens play 
any role in the formation of transloca-
tions in prostate cancer cells that lacked 
these gene fusions. Remarkably, they 
found that after induction of genotoxic 
stress by irradiation far more translo-
cations formed in prostate cancer cells 
when androgens were present than when 
they were absent (Lin et al., 2009). Their 
ensuing quest to unravel how androgens promote the formation of translocations 
has lead to the discovery of several new 
potential translocation mechanisms.
The key to how androgens promote 
translocation frequency lies in the fact 
that the translocation regions, TMPRSS2, 
ERG, and ETV, all contain binding sites 
for the androgen receptor (AR) near their 
breakpoints. Lin et al. show that after 
treatment of prostate cancer cells with 
androgens, there is rapid recruitment of 
AR to these sites. This has several severe 
consequences. To start with, AR is known 
to be a strong transcriptional activa-
tor, and, not surprisingly, its recruitment 
induces changes in higher-order chro-
matin structure and epigenetic modifica-
tions indicative of open, active chroma-
tin (Figure 1). This may make these sites 
more susceptible to breakage. AR bind-
ing also induces changes in the physi-
cal location of genomic regions within 
the nucleus, bringing them into close 
spatial proximity and thus predisposing 
them for their eventual fusion (Figure 1). 
However, the most fateful consequence 
of AR binding is the recruitment of cel-
lular machinery that can cause DNA 
double-strand breaks when the cells are 
exposed to genotoxic stress. In particu-
lar, AR attracts the activation-induced 
cytidine deaminase (AID) via its cofac-
tor, Gadd45, to chromatin. AID is a key 
factor in somatic hypermutation (SHM) 
and class-switch recombination (CSR) 
in B lymphoid cells, where it contributes 
to DNA breakage during the process of 
generating antibody diversity (Figure 1).
These results tell us that transcription 
factor binding and higher-order chroma-
tin structure play a key role in determin-
ing the chromosomal sites of transloca-
tion breakpoints. These observations in Cell 139, Dprostate cells echo recent observations 
on the contribution of transcription and 
chromatin structure in the formation of 
translocations. Analysis of transloca-
tion mechanisms in anaplastic large-cell 
lymphoma, which is characterized by a 
t(2;5) translocation, revealed that several 
genes in the vicinity of the translocation 
breakpoints are transcriptionally active 
before translocations occur (Mathas et 
al., 2009). Similar to the situation in pros-
tate cancer, it was hypothesized that 
the aberrant expression of these genes 
was caused by inappropriate binding of 
transcription factors or by changes to 
higher-order chromatin structure.
The findings by Lin et al. also strengthen 
the notion that translocations preferen-
tially occur between proximally posi-
tioned chromosomes (Misteli and Souto-
glou, 2009). Correlations between spatial 
proximity and translocation frequency are 
now widespread and have been demon-
strated for many tumor translocations, 
including MYC-IGH in Burkitt’s lymphoma 
and BCR-ABL in chronic myeloid leuke-
mia (Misteli and Soutoglou, 2009). Simi-
lar to the situation for TMPRSS2:ETV1, 
in anaplastic large-cell lymphoma, the 
translocating genome regions on chro-
mosomes 2 and 5 undergo repositioning 
prior to translocation, moving them into 
proximity (Mathas et al., 2009). This juxta-
position contributes to the increased like-
lihood of translocation, as demonstrated 
by the fact that both the anaplastic large-
cell lymphoma and prostate transloca-
tions readily form upon irradiation of cells 
under conditions in which these genomic 
regions are in proximity (Lin et al., 2009; 
Mani et al., 2009; Mathas et al., 2009). 
Thus, it seems that alterations in chro-
matin structure, possibly triggered by ecember 11, 2009 ©2009 Elsevier Inc. 1047
Figure 1. Pathways to Cancer Translocations
Translocations occur by breakage and illegitimate joining of distinct genomic regions (shown in orange 
and green) either within the same chromosome or on separate chromosomes. Multiple pathways contrib-
ute to the formation of translocations. In one pathway, androgen receptor (AR) binds to its target sites in 
the genome upon stimulation by androgen. Binding of AR induces local chromatin remodeling and leads 
to spatial association of multiple AR target sites, possibly making these regions susceptible to breakage. 
Upon genotoxic stress such as irradiation, AR recruits the activation-induced cytidine deaminase AID, 
which is capable of inducing DNA double-strand breaks. In a second pathway, ORF2, which is overex-
pressed in cancer cells, associates with target sites in the genome in response to androgen signaling 
and induces double-strand breaks. Determinants of ORF2 expression and targeting are unknown. Juxta-
posed chromosomes containing persistent double-strand breaks induced by either mechanism are prone 
to translocation. Such translocations may contribute to tumorigenesis.1048 Cell 139, December 11, 2009 ©2009 Elsevier Inc.binding of transcription factors, are a far 
upstream event in the formation of trans-
locations (Figure 1).
The observations by Lin et al. also 
expand the spectrum of functions for 
AID and support its proposed role in 
tumor formation. AID has a well-estab-
lished, important function in B lymphoid 
cells, where it is critical in the intro-
duction of double-strand breaks in the 
immunoglobulin genes during SHM and 
CSR. That AID activity also contributes 
to translocation formation has been sug-
gested previously, based on the finding 
that AID is required for the formation 
of DNA breaks in c-MYC prior to the 
formation of MYC-IGH translocations 
in Burkitt’s lymphoma (Robbiani et al., 
2008). Although such “off-target” AID 
activity is well defined in B cells, Lin et 
al. demonstrate that AID also has del-
eterious effects in non-B cell types and 
that neither its expression nor its activity 
is restricted to B cells (Lin et al., 2009). 
The finding that AID is a critical factor in 
the formation of prostate cell transloca-
tions now raises the possibility that AID 
is a general translocation factor and may 
be a key player in the formation of many 
translocations, including those in solid 
tumors.
But AR and AID are not the full story. 
Lin et al. also find a contribution to the 
translocation frequency by the ORF2 
endonuclease encoded by the LINE-1 
retroelement (Lin et al., 2009). ORF2, 
which is present at higher levels in pros-
tate cancer cells than in normal cells, was 
selectively recruited to the translocation 
regions in an androgen-dependent fash-
ion. However, the effect of ORF2 seems 
to establish an independent transloca-
tion pathway, since it was not depen-
dent on AID and ORF2 does not interact 
with AR (Figure 1). It will be of interest to 
determine why and how ORF2 activity is 
elevated in transformed cells and what 
determines ORF2 recruitment.
These observations point to a model 
in which translocations are a down-
stream event of transcription factor 
binding and chromatin remodeling. 
The parallels between prostate cancer 
and anaplastic large cell lymphoma 
are striking, and the fact that similar 
mechanisms are at play in both solid 
tumors and lymphoma suggest that 
this will be a universal mechanism. The 
results reveal several novel aspects of 
translocation mechanisms, but also 
raise many questions. Why do translo-
cations occur only between TMPRSS2 
and its particular translocation part-
ners, when AR binds to many genomic 
sites? Perhaps other translocations do 
occur but are lost because they do not 
provide a growth or survival advantage. 
Alternatively, the epigenetic makeup 
of the breakpoint regions, their spa-
tial arrangement, or the involvement of 
AR cofactors or noncoding RNAs may 
underlie recurrent translocations. It will 
be important to characterize the nature 
of chromatin structure and epigenetic 
modifications at the breakpoints and to 
determine how these features influence 
the recruitment of AR and AID. Also, is 
AID frequently expressed in prostate 
carcinoma tissues, and, if so, does it 
correlate with disease malignancy?
Maybe the most important concep-
tual implication of the reported find-
ings is the challenge to how we think 
about translocations. Generally, we 
have assumed that translocations occur 
more or less randomly in the genome by Unlike the static protein structures that 
grace journal pages, real proteins in solu-
tion are dynamic. The internal motions of 
a protein can be depicted schematically 
in terms of a free-energy landscape—a 
terrain map describing protein conforma-
tional space (Dill and Chan, 1997; Frauen-
felder et al., 1991). Different conformations 
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nitrogen regulatory protein NtrC bstochastic DNA double-strand breaks. 
The enrichment of particular transloca-
tions was then thought to be purely the 
consequence of a selection process in 
which only certain subpopulations of 
cells survive as the randomly generated 
translocation affords them a growth 
advantage. This idea needs rethinking. 
The recent results on blood and solid 
tumors suggest instead that breaks in 
the genome occur in a nonrandom fash-
ion and that their sites are determined by 
where transcription factors bind. It then 
seems that in addition to selection on 
the basis of growth properties, recurrent 
translocations in a tumor may also be a 
reflection of transcription factor binding 
patterns and the higher-order chroma-
tin structure landscape. As transcription 
factor binding and epigenetic patterns 
are often cell-type specific, they may 
be a plausible explanation for the cell 
lineage- and tumor type-specific occur-
rence of some cancer translocations. 
An interesting possibility is that we can 
begin thinking about superimposing 
currently available transcription factor 
binding and epigenetic maps with the Cell 139, D
(the “valleys”) are separated by free-
energy barriers (the “hills”): the difference 
between the free energies of individual 
conformations determines their relative 
abundance, whereas the size and nature 
of the energy barriers determine the kinet-
ics of conformational exchange (Figure 1). 
Although we have gained much insight 
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 precisely shift from one confor
drogen bonds are critical to the 
etween its native state and its alocations of breakpoints in a wide array 
of cancers and in this way identify the 
molecular triggers of specific cancer 
translocations. If successful, then we 
have truly entered a new era in under-
standing cancer and its translocations.
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into the various conformational states of 
proteins in solution (Boehr et al., 2009), 
much less is understood about the nature 
of the barriers separating different confor-
mations and the molecular mechanisms of 
the conformational transitions. The find-
ings presented in this issue by Gardino et 
al. (2009) on the nitrogen regulatory protein 
ke  
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conformational transition of the 
ctive state.
